These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 25088841

  • 1. Utility of GATA3 immunohistochemistry for diagnosis of metastatic breast carcinoma in cytology specimens.
    Braxton DR, Cohen C, Siddiqui MT.
    Diagn Cytopathol; 2015 Apr; 43(4):271-7. PubMed ID: 25088841
    [Abstract] [Full Text] [Related]

  • 2. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens.
    Shield PW, Papadimos DJ, Walsh MD.
    Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220
    [Abstract] [Full Text] [Related]

  • 3. GATA3 immunohistochemistry expression in histologic subtypes of primary breast carcinoma and metastatic breast carcinoma cytology.
    Deftereos G, Sanguino Ramirez AM, Silverman JF, Krishnamurti U.
    Am J Surg Pathol; 2015 Sep; 39(9):1282-9. PubMed ID: 26274030
    [Abstract] [Full Text] [Related]

  • 4. GATA3 expression in clinically useful groups of breast carcinoma: a comparison with GCDFP15 and mammaglobin for identifying paired primary and metastatic tumors.
    Yang Y, Lu S, Zeng W, Xie S, Xiao S.
    Ann Diagn Pathol; 2017 Feb; 26():1-5. PubMed ID: 28038704
    [Abstract] [Full Text] [Related]

  • 5. The Novel Marker GATA3 is Significantly More Sensitive Than Traditional Markers Mammaglobin and GCDFP15 for Identifying Breast Cancer in Surgical and Cytology Specimens of Metastatic and Matched Primary Tumors.
    Sangoi AR, Shrestha B, Yang G, Mego O, Beck AH.
    Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):229-37. PubMed ID: 25906123
    [Abstract] [Full Text] [Related]

  • 6. Young investigator challenge: The utility of GATA3 immunohistochemistry in the evaluation of metastatic breast carcinomas in malignant effusions.
    Lew M, Pang JC, Jing X, Fields KL, Roh MH.
    Cancer Cytopathol; 2015 Oct; 123(10):576-81. PubMed ID: 26465236
    [Abstract] [Full Text] [Related]

  • 7. Utility of different immunostains for diagnosis of metastatic breast carcinomas in both surgical and cytological specimens.
    Hou Y, Shen R, Chaudhary S, Tonkovich D, Li Z.
    Ann Diagn Pathol; 2017 Oct; 30():21-27. PubMed ID: 28965624
    [Abstract] [Full Text] [Related]

  • 8. Folate Receptor Alpha Immunohistochemistry in Cytology Specimens of Metastatic Breast Carcinoma.
    Sheikh UN, Cohen C, Siddiqui MT.
    Acta Cytol; 2015 Oct; 59(4):298-304. PubMed ID: 26413911
    [Abstract] [Full Text] [Related]

  • 9. Fine needle aspirate cell blocks are reliable for detection of hormone receptors and HER-2 by immunohistochemistry in breast carcinoma.
    Bueno Angela SP, Viero RM, Soares CT.
    Cytopathology; 2013 Feb; 24(1):26-32. PubMed ID: 22220518
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic utility and sensitivities of GATA3 antibodies in triple-negative breast cancer.
    Krings G, Nystrom M, Mehdi I, Vohra P, Chen YY.
    Hum Pathol; 2014 Nov; 45(11):2225-32. PubMed ID: 25150746
    [Abstract] [Full Text] [Related]

  • 11. Can GATA3 Immunocytochemistry be Utilized as a Reliable Diagnostic Marker for Metastatic Breast Carcinoma in Cytological Materials? A Comparative Study with Mammaglobin and GCDFP-15 Expression.
    Hafez NH, Shaaban HM.
    Turk Patoloji Derg; 2018 Nov; 34(2):143-149. PubMed ID: 29235613
    [Abstract] [Full Text] [Related]

  • 12. Utility of GATA3, mammaglobin, GCDFP-15, and ER in the detection of intrathoracic metastatic breast carcinoma.
    Dyhdalo KS, Booth CN, Brainard JA, Croyle MC, Kolosiwsky AM, Goyal A, Gildea TR, Almeida FA, Nassar A, Reynolds JP.
    J Am Soc Cytopathol; 2015 Nov; 4(4):218-224. PubMed ID: 31051757
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic utility of mammaglobin and GCDFP-15 in the identification of metastatic breast carcinoma in fluid specimens.
    Yan Z, Gidley J, Horton D, Roberson J, Eltoum IE, Chhieng DC.
    Diagn Cytopathol; 2009 Jul; 37(7):475-8. PubMed ID: 19217055
    [Abstract] [Full Text] [Related]

  • 14. Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors.
    Chia SY, Thike AA, Cheok PY, Tan PH.
    Breast; 2010 Oct; 19(5):355-9. PubMed ID: 20347310
    [Abstract] [Full Text] [Related]

  • 15. GATA3 expression in morphologic subtypes of breast carcinoma: a comparison with gross cystic disease fluid protein 15 and mammaglobin.
    Wendroth SM, Mentrikoski MJ, Wick MR.
    Ann Diagn Pathol; 2015 Feb; 19(1):6-9. PubMed ID: 25544392
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung.
    Hattori Y, Yoshida A, Yoshida M, Takahashi M, Tsuta K.
    Pathol Int; 2015 Jun; 65(6):286-92. PubMed ID: 25727644
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.